Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marina Harume Imanishe"'
Autor:
André Luis Victor Bonfim, Germana Alves deBrito, Aline Lourenço Baptista, Luis André Silvestre Andrade, Marina Harume Imanishe, Benedito Jorge Pereira
Publikováno v:
Nursing Open, Vol 10, Iss 7, Pp 4480-4489 (2023)
Abstract Aim To evaluate complications after PICC use in cancer patients. Design This was a clinical and retrospective study in which the risk factors and complications of PICC use were evaluated. Methods This study was carried out in the patient, em
Externí odkaz:
https://doaj.org/article/ad518b2f1fc14a30a45859dcf4e68b47
Autor:
Anna Carolina Macieira Feitosa Mota, Joubert Araújo Alves, Gabriel Stecca Canicoba, Germana Alves de Brito, Garles Miller Matias Vieira, Aline Lourenço Baptista, Luis André Silvestre Andrade, Marina Harume Imanishe, Benedito Jorge Pereira
Publikováno v:
Revista Brasileira de Cancerologia, Vol 69, Iss 1 (2023)
Introduction: Hematologic malignancies, including lymphomas and leukemias, may be treated with autologous or allogeneic bone marrow transplantation. However, these approaches can increase the risk of infection, sepsis, graft-versus-host disease, and
Externí odkaz:
https://doaj.org/article/6027299f4e124034a0604679a1e0a938
Autor:
Fabiana Almeida Antonio Bienes, Germana Alves deBrito, Joubert Araujo Alves, Aline Lourenco Baptista, Luis André Silvestre Andrade, Marina Harume Imanishe, Benedito Jorge Pereira
Publikováno v:
Clinical Case Reports, Vol 10, Iss 3, Pp n/a-n/a (2022)
Abstract Nephrotic syndrome (NS) may occur after or concomitantly with malignancy. The use of immunosuppressive approaches in patients with cancer and NS is controversial, especially when the association between the pathologies is unclear. The aim of
Externí odkaz:
https://doaj.org/article/0ce85c3363fd4f16b1e7f3dc3480fa1a
Autor:
Alexandre Ricardo Da Silva Fernandes, Germana Alves de Brito, Aline Lourenço Baptista, Luis André Silvestre Andrade, Marina Harume Imanishe, Benedito Jorge Pereira
Publikováno v:
Health Science Reports, Vol 5, Iss 1, Pp n/a-n/a (2022)
Abstract Background and Aims Cisplatin (CDDP) is used as the first line of treatment for some tumors, but its use may be restricted due to its nephrotoxicity. Carboplatin (CARBO) and oxaliplatin (OXA) are less nephrotoxic alternatives to CDDP. This s
Externí odkaz:
https://doaj.org/article/f7beaf323d544086b13f3a17bc971d0a
Autor:
Patricia Murari, Germana Alves de Brito, Joubert Araujo Alves, Garles Miller Matias Vieira, Aline Lourenço Baptista, Luis André Silvestre Andrade, Marina Harume Imanishe, Benedito Jorge Pereira
Publikováno v:
Journal of Onco-Nephrology. 6:10-16
Introduction: Treatment of multiple myeloma (MM) with chemotherapy and autologous bone marrow transplantation (BMT) commonly results in renal dysfunction associated with early mortality. Prognostic scores for MM are assessed by either Durie and Salmo